This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2021 Feb 25;384(8):727-743.

doi: 10.1056/NEJMra2021838.

β-Thalassemias

Ali T Taher¹, Khaled M Musallam¹, M Domenica Cappellini¹

Affiliations

Affiliation

¹ From the Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon (A.T.T.); the International Network of Hematology, London (K.M.M.); and the Department of Clinical Sciences and Community, University of Milan, Ca' Granda Foundation IRCCS Maggiore Policlinico Hospital, Milan (M.D.C.).

PMID: 33626255
DOI: 10.1056/NEJMra2021838

Review

β-Thalassemias

Ali T Taher et al. N Engl J Med. 2021.

. 2021 Feb 25;384(8):727-743.

doi: 10.1056/NEJMra2021838.

Authors

Ali T Taher¹, Khaled M Musallam¹, M Domenica Cappellini¹

Affiliation

¹ From the Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon (A.T.T.); the International Network of Hematology, London (K.M.M.); and the Department of Clinical Sciences and Community, University of Milan, Ca' Granda Foundation IRCCS Maggiore Policlinico Hospital, Milan (M.D.C.).

PMID: 33626255
DOI: 10.1056/NEJMra2021838

No abstract available

PubMed Disclaimer

Comment in

β-Thalassemias.
Thong MK, Ngim CF. Thong MK, et al. N Engl J Med. 2021 Jun 3;384(22):2165. doi: 10.1056/NEJMc2105064. N Engl J Med. 2021. PMID: 34077655 No abstract available.
β-Thalassemias.
Georgalas I, Petrou P, Kanakis M. Georgalas I, et al. N Engl J Med. 2021 Jun 3;384(22):2165-2166. doi: 10.1056/NEJMc2105064. N Engl J Med. 2021. PMID: 34077656 No abstract available.

Similar articles

Luspatercept: A Review in Transfusion-Dependent Anaemia due to Myelodysplastic Syndromes or β-Thalassaemia.
Kang C, Syed YY. Kang C, et al. Drugs. 2021 Jun;81(8):945-952. doi: 10.1007/s40265-021-01527-9. Epub 2021 May 10. Drugs. 2021. PMID: 33970460 Review.
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ, Chew LP, Bee PC, Lim SM, Lu MY, Tantiworawit A, Ganeva P, Gercheva L, Shah F, Neufeld EJ, Thompson A, Laadem A, Shetty JK, Zou J, Zhang J, Miteva D, Zinger T, Linde PG, Sherman ML, Hermine O, Porter J, Piga A; BELIEVE Investigators. Cappellini MD, et al. N Engl J Med. 2020 Mar 26;382(13):1219-1231. doi: 10.1056/NEJMoa1910182. N Engl J Med. 2020. PMID: 32212518 Clinical Trial.
Management of non-transfusion-dependent β-thalassemia (NTDT): The next 5 years.
Musallam KM, Rivella S, Taher AT. Musallam KM, et al. Am J Hematol. 2021 Mar 1;96(3):E57-E59. doi: 10.1002/ajh.26055. Epub 2020 Dec 9. Am J Hematol. 2021. PMID: 33219704 No abstract available.
Luspatercept: First Approval.
Markham A. Markham A. Drugs. 2020 Jan;80(1):85-90. doi: 10.1007/s40265-019-01251-5. Drugs. 2020. PMID: 31939073 Review.
β-Thalassemia: evolving treatment options beyond transfusion and iron chelation.
Langer AL, Esrick EB. Langer AL, et al. Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):600-606. doi: 10.1182/hematology.2021000313. Hematology Am Soc Hematol Educ Program. 2021. PMID: 34889443 Free PMC article. Review.

See all similar articles

Cited by

Lipid nanoparticle-mediated mRNA delivery to CD34⁺ cells in rhesus monkeys.
Kim H, Zenhausern R, Gentry K, Lian L, Huayamares SG, Radmand A, Loughrey D, Podilapu AR, Hatit MZC, Ni H, Li A, Shajii A, Peck HE, Han K, Hua X, Jia S, Martinez M, Lee C, Santangelo PJ, Tarantal A, Dahlman JE. Kim H, et al. Nat Biotechnol. 2024 Nov 22. doi: 10.1038/s41587-024-02470-2. Online ahead of print. Nat Biotechnol. 2024. PMID: 39578569
A particular focus on the prevalence of α-thalassemia and β-thalassemia among pregnant women in Changsha County, Hunan Province.
Xia Y, Huang C, Yang M, Zhang M, Lu Y. Xia Y, et al. Front Genet. 2024 Nov 7;15:1422462. doi: 10.3389/fgene.2024.1422462. eCollection 2024. Front Genet. 2024. PMID: 39574796 Free PMC article.
Identifying thresholds for meaningful improvements in NTDT-PRO scores to support conclusions about treatment benefit in clinical studies of patients with non-transfusion-dependent beta-thalassaemia: analysis of pooled data from a phase 2, double-blind, placebo-controlled, randomised trial.
Taher AT, Musallam KM, Viprakasit V, Kattamis A, Lord-Bessen J, Yucel A, Guo S, Pelligra CG, Shields AL, Shetty JK, Glassberg MB, Bueno LM, Cappellini MD. Taher AT, et al. BMJ Open. 2024 Nov 14;14(11):e085234. doi: 10.1136/bmjopen-2024-085234. BMJ Open. 2024. PMID: 39542473 Free PMC article. Clinical Trial.
Association of age to nutritional status and muscle mass in children with transfusion-dependent β-thalassemia: a cross-sectional study.
Wang L, Zhang L, Yang Y, Luo Y, Wang L, Patil S. Wang L, et al. Front Nutr. 2024 Oct 25;11:1493502. doi: 10.3389/fnut.2024.1493502. eCollection 2024. Front Nutr. 2024. PMID: 39525502 Free PMC article.
Assessment of diagnostic accuracy of Gazelle: A point-of-care testing device for screening β-thalassemia trait.
Singh N, Seth T, Dass J. Singh N, et al. Indian J Med Res. 2024 Aug;160(2):194-200. doi: 10.25259/ijmr_1986_23. Indian J Med Res. 2024. PMID: 39513207 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- scite Smart Citations